Faro Capital
VC Fund
Buenos Aires, Argentina
Faro Capital is a VC fund in Buenos Aires focused on Biotechnology and Gaming. FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Faro Capital invests in
Stages Faro Capital invests in
Countries Faro Capital invests in
Round sizes
Round size
- Series A
- $2.8M–$25M
Investment Focus
Industry
- Biotechnology 2 (40%)
- Gaming 1 (20%)
- Medical 1 (20%)
- Genetics 1 (20%)
- Software 1 (20%)
Stage
- Series A 3 (60%)
- Seed 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- Sweden 4 (80%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bluwhale
|
Established in 2022, Bluwhale is a state-of-the-art artificial intelligence platform that specializes in extracting and analyzing comprehensive data from content across various blockchains, as well as contextualizing NFT data for personalization and discovery purposes. This pioneering approach equips DApps and marketplaces with the intelligencenecessary to boost retention, engagement, and revenue. Offering user-friendly tools and analytics, Bluwhale delivers a complete understanding of content, tokens, smart contracts, and wallet activities by employing a graph representation of the underlying data.Through cataloging, labeling, and examining over 200 million NFTs and wallets, Bluwhale enhances on-chain data with valuable contextual information, assisting users in making informed investment decisions and facilitating the seamless integration of data-driven intelligence into their applications. | $25M / Series A / Jan 28, 2025 | |
Bionamic
|
Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results. | $387K / Venture - Series Unknown / Feb 28, 2024 | |
IntuiCell
|
IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform. | Seed / Jun 22, 2021 | |
Aligned Bio
|
Aligned Bio develops advanced nanowire biosensor platforms. Sensors that are fast, accurate, and highly sensitive are becoming increasingly important in fields ranging from biomedicine to water purification, public safety, and personal electronics. Aligned Bio improves sensitivity by using patented nanowire production and alignment methods. | $2.8M / Series A / Feb 09, 2021 | |
SAGA Diagnostics
|
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity. | $3.9M / Series A / Jun 11, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Faro Capital invest in?
Faro Capital invests primarily in Biotechnology, Gaming and Medical startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Faro Capital's check size?
Faro Capital typically joins rounds of $2.8M–$25M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Faro Capital participates in.
When did Faro Capital last invest?
The most recent investment recorded for Faro Capital closed in Jan 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
